D. E. Shaw & Co., Inc. Omeros Corp Transaction History
D. E. Shaw & Co., Inc.
- $107 Billion
- Q3 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Omeros Corp stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 1,605,240 shares of OMER stock, worth $16.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,605,240Holding current value
$16.2 Million% of portfolio
0.01%Shares
29 transactions
Others Institutions Holding OMER
# of Institutions
120Shares Held
25.6MCall Options Held
228KPut Options Held
630K-
Ingalls & Snyder LLC New York, NY4.54MShares$45.9 Million0.7% of portfolio
-
Black Rock Inc. New York, NY4.1MShares$41.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.26MShares$33 Million0.0% of portfolio
-
Stifel Financial Corp St. Louis, MO1.9MShares$19.3 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.34MShares$13.5 Million0.0% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $634M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...